Wright State University and Premier Health Partners will form the Clinical Trials Research Alliance to increase medical research opportunities for physicians and clinicians and boost access to clinical trials in the Dayton region.
This major public-private initiative combines Wright State’s strong biomedical research programs with the clinical resources of the region’s leading hospital system. Premier Health Partners is making a major investment of $4 million over five years to support the infrastructure of the alliance.
BioOhio, the state’s bioscience membership and development organization, this week announced six additions to its Board of Trustees. The new trustees are:
Thomas Boat, M.D., Christian R. Holmes Professor & Dean, College of Medicine Vice President for Health Affairs, University of Cincinnati;
Frank Douglas, Ph.D., M.D., President & CEO, Austen BioInnovation Institute ;
Midwest health care companies attracted $810 Million in new investments across 178 companies in 2011 according to the BioEnterprise Midwest Health Care Venture Investment Report. Total dollars are up by 10% from 2010; however it remains below the peak year of 2007 ($1.2 million).
Minnesota ($223 million), Ohio ($178 million), and Missouri ($169 million) led Midwestern states in attracting investment dollars. Minneapolis, Cleveland, and St. Louis were the leaders among Midwest regions.
Ohio’s $178 million in 2011 amounts to a 17% increase compared to last year, and a 40% increase versus 2009. ::read more::
Cleveland-based Athersys announced today two grants that will further advance its MultiStem product programs and cell therapy platform.
Athersys was awarded a SBIR Fast-Track grant of up to $1.9 million from the National Institute of Neurological Disorders and Stroke (NINDS) to develop MultiStem for the treatment of traumatic brain injury. In addition, Athersys’ subsidiary based in Belgium, ReGenesys BVBA, was awarded a $1.2 million (EURO0.9 million) grant from the Belgium’s Agency for Innovation by Science and Technology (IWT) to further develop cell therapy formulations and manufacturing capabilities. ::read more::
Amylin Pharmaceuticals and Alkermes announced Friday that the FDA has approved Bydureon (exenatide extended-release for injectable suspension) – the first once-weekly treatment for type 2 diabetes. The drug will be available in pharmacies nationwide in February. Bydureon, which had previously received marketing authorization in the European Union, is produced at Amylin’s West Chester, Ohio, facility.
University of Cincinnati biomedical engineering professor David Butler, PhD, has been named the recipient of the 2012 H.R. Lissner Medal, given by the American Society of Mechanical Engineers (ASME), for his contributions to the field of biomedical engineering. The award recognizes Butler’s achievements in bioengineering spanning his research contributions, development of new methods of measurement, [...]
On average in the U.S., half of the 2,000 U.S. patients who receive heart transplants each year eventually suffer from acute or chronic rejection of the donated organs. Researchers at The University of Toledo are receiving financial support from the American Heart Association to address the problem. Dr. Wenhao Chen, clinical assistant professor of medical microbiology [...]
Battelle and San Diego-based Zogenix have signed a Letter of Intent to enter into an exclusive co-marketing and technology development option agreement to utilize Zogenix’s DosePro needle-free drug delivery technology for new commercial out-licensing opportunities. DosePro technology enables needle-free medication delivery under the skin. Instead of a needle, DosePro technology uses a small amount of [...]
Hiroyuki Fujita, the founder, president, and CEO of Quality Electrodynamics (QED), was scheduled to be in Asia this week. Funny how a call from the White House can change your plans. Last Friday he received an invitation to sit with Michelle Obama in the first lady’s box for President Obama’s State of The Union address [...]
The BioOhio Scholarship competition enters its third year in 2012 (click for more info and application), and we expect hundreds of applications again this year. Ohio high school seniors will be competing for four $1,250 non-renewable scholarships. Spread the word (i.e., this article) to family and friends via email, LinkedIn, Twitter, and Facebook. We are in fundraising [...]
Midwest health care companies attracted $810 Million in new investments across 178 companies in 2011 according to the 
